Liver resection for multimodal treatment of breast cancer metastases: identification of prognostic factors

Liver resection (LR) within a multimodal treatment concept of hepatic metastases (HM) that results from breast cancer has been controversially discussed. The aim of this study was to evaluate the outcome of LR in patients with hepatic breast cancer metastases.

Salvato in:
Dettagli Bibliografici
Autori principali: Hoffmann, Katrin (Autore) , Franz, Clemens (Autore) , Hinz, Ulf (Autore) , Schirmacher, Peter (Autore) , Herfarth, Christian (Autore) , Eichbaum, Michael H. R. (Autore) , Büchler, Markus W. (Autore) , Schemmer, Peter (Autore)
Natura: Article (Journal)
Lingua:inglese
Pubblicazione: 09 February 2010
In: Annals of surgical oncology
Year: 2010, Volume: 17, Fascicolo: 6, Pages: 1546-1554
ISSN:1534-4681
DOI:10.1245/s10434-010-0931-5
Accesso online:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1245/s10434-010-0931-5
Testo
Note sull'autore:Katrin Hoffmann, Clemens Franz, Ulf Hinz, Peter Schirmacher, Christian Herfarth, Michael Eichbaum, Markus W. Büchler, and Peter Schemmer
Descrizione
Riassunto:Liver resection (LR) within a multimodal treatment concept of hepatic metastases (HM) that results from breast cancer has been controversially discussed. The aim of this study was to evaluate the outcome of LR in patients with hepatic breast cancer metastases.
Descrizione del documento:Gesehen am 13.03.2023
Descrizione fisica:Online Resource
ISSN:1534-4681
DOI:10.1245/s10434-010-0931-5